These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34067194)

  • 1. Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery.
    Pereira R; Silva SG; Pinheiro M; Reis S; Vale MLD
    Membranes (Basel); 2021 May; 11(5):. PubMed ID: 34067194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation enhancers in transdermal drug delivery: benefits and limitations.
    Kováčik A; Kopečná M; Vávrová K
    Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic transdermal permeation enhancers: structure-activity relationships.
    Vávrová K; Zbytovská J; Hrabálek A
    Curr Med Chem; 2005; 12(19):2273-91. PubMed ID: 16178785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic Liquids as Potential and Synergistic Permeation Enhancers for Transdermal Drug Delivery.
    Sidat Z; Marimuthu T; Kumar P; du Toit LC; Kondiah PPD; Choonara YE; Pillay V
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30813375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different enhancers on the transdermal permeation of insulin analog.
    Yerramsetty KM; Rachakonda VK; Neely BJ; Madihally SV; Gasem KA
    Int J Pharm; 2010 Oct; 398(1-2):83-92. PubMed ID: 20667506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Dvořáková K; Štěpánek P; Kroupová J; Zbytovská J
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers.
    Rambharose S; Kalhapure RS; Jadhav M; Govender T
    Drug Deliv Transl Res; 2017 Apr; 7(2):333-345. PubMed ID: 28160257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to determination of permeation enhancer action efficacy and sites: Molecular mechanism investigated by quantitative structure-activity relationship.
    Yang D; Liu C; Quan P; Fang L
    J Control Release; 2020 Jun; 322():1-12. PubMed ID: 32169535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
    Funke AP; Günther C; Müller RH; Lipp R
    J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches.
    Hmingthansanga V; Singh N; Banerjee S; Manickam S; Velayutham R; Natesan S
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel skin permeation enhancers based on amino acid ester ionic liquid: Design and permeation mechanism.
    Zheng L; Zhao Z; Yang Y; Li Y; Wang C
    Int J Pharm; 2020 Feb; 576():119031. PubMed ID: 31953082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Acid Esters of G
    Chaudhari KS; Akamanchi KG
    ACS Biomater Sci Eng; 2018 Dec; 4(12):4008-4020. PubMed ID: 33418801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of improved permeation enhancers for transdermal drug delivery.
    Godavarthy SS; Yerramsetty KM; Rachakonda VK; Neely BJ; Madihally SV; Robinson RL; Gasem KA
    J Pharm Sci; 2009 Nov; 98(11):4085-99. PubMed ID: 19697392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer.
    Liu C; Farah N; Weng W; Jiao B; Shen M; Fang L
    Eur J Pharm Sci; 2019 Oct; 138():105009. PubMed ID: 31306781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of surfactants as penetration enhancers in transdermal drug delivery.
    Som I; Bhatia K; Yasir M
    J Pharm Bioallied Sci; 2012 Jan; 4(1):2-9. PubMed ID: 22368393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation enhancers for transdermal drug delivery.
    Sinha VR; Kaur MP
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1131-40. PubMed ID: 11068686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.